Details of the Drug

General Information of Drug (ID: DMCIYNO)

• Drug Name: Omidubicel

Indication

Disease Entry	ICD 11	Status	REF
Hematologic tumour	2B33.Y	Phase 3	[1]

• Affected Organisms: Humans and other mammals
• Drug Type: Cell therapy
• Cross-matching ID:
  UNII: ET4JC4S66E
  DrugBank ID: DB17132
  TTD ID: D0UXJ2

References

• [1] ClinicalTrials.gov (NCT04260698) Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies. U.S. National Institutes of Health.